These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 400003)

  • 1. [Proinsulin and a-component antibodies in diabetics treated with monocomponent and conventional insulin].
    Gamba S; Barbero PL; Bollati C; Castellazzi R; D'Adda A; Bruni B
    Minerva Dietol Gastroenterol; 1979; 25(3):309-14. PubMed ID: 400003
    [No Abstract]   [Full Text] [Related]  

  • 2. Proinsulin and A-component antibodies in diabetics after long-term monocomponent insulin treatment.
    Bruni B; Gamba S; Regis G; Turco GL
    Diabetologia; 1978 Mar; 14(3):165-9. PubMed ID: 566232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behaviour of insulin antibodies in diabetics treated with different insulins.
    Mincu I; Cheţa D; Ionescu-Tîrgovişte C; Mirodon Z; Sîntu E
    Med Interne; 1980; 18(4):347-52. PubMed ID: 7006044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum levels of insulin-binding antibodies treated with monocomponent insulin].
    Czyzyk A; Lawecki J; Rogala H; Miedzińska E; Popik-Hankiewicz A
    Pol Tyg Lek; 1974 Feb; 29(8):301-4. PubMed ID: 4856084
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experiences in the treatment of diabetes with insulins of monocomponent (MC) and monospecies (MS) type].
    Andreani D; Iavicoli M; Colletti A; Menzinger G
    Folia Endocrinol; 1972 Dec; 25(6):516-39. PubMed ID: 4581824
    [No Abstract]   [Full Text] [Related]  

  • 6. [The antigenicity of various new chromatographically purified depot insulin preparations].
    Graber D; Fankhauser S
    Schweiz Med Wochenschr; 1978 Nov; 108(46):1807-9. PubMed ID: 715418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The study of insulin antibodies in different forms of diabetes mellitus].
    Mincu I; Ionescu-Tirgovişte C; Cheţa D; Simionescu L; Mirodon Z; Vasilescu V; Bruckner I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(5):421-8. PubMed ID: 44565
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in daily insulin requirement in diabetics switched to monocomponent insulin treatment].
    Bruni B; Turco GL
    Minerva Med; 1973 Nov; 64(80):4224-31. PubMed ID: 4765430
    [No Abstract]   [Full Text] [Related]  

  • 9. Insulin antibodies in diabetics receiving a single type of insulin.
    Mincu I; Cheţa D
    Med Interne; 1982; 20(1):9-13. PubMed ID: 6765628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term clinical trial with porcine monocomponent lente insulin (Monotard).
    Bruni B; Bruni Bocher K; Gamba S; Giolitti A; Rittatore R; Turco GL
    Panminerva Med; 1977; 19(4):247-54. PubMed ID: 593701
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experiences with monocomponent insulins].
    Bruni Bocher K; Giolitti A; Turco GL; Benedetto P; Bruni B
    Minerva Med; 1975 Mar; 66(19):909-30. PubMed ID: 1124144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [KH metabolic pattern and insulin antibody level during treatment of diabetes mellitus with conventional and/or prepurified insulin preparations].
    Göbel P; Kramer W; Heni F
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1426-9. PubMed ID: 611859
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of insulin lipoatrophy with monocomponent insulin.
    Teuscher A
    Diabetologia; 1974 Jun; 10(3):211-4. PubMed ID: 4845721
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum levels of insulin-binding antibodies in diabetic patients treated with monocomponent insulin.
    Czyzyk A; Lawecki J; Rogala H; Miedzińska E; Popik-Hankiewicz A
    Diabetologia; 1974 Jun; 10(3):233-6. PubMed ID: 4845724
    [No Abstract]   [Full Text] [Related]  

  • 15. The immunogenic properties of highly purified insulin preparations: The clinical importance of insulin-binding antibodies.
    Anderson OO
    Acta Endocrinol (Copenh); 1975 Apr; 78(4):723-35. PubMed ID: 1173962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin antibody formation during long-term treatment with monocomponent and monospecies insulin.
    Piers DA; Sluiter WJ; Reitsma WD; Doorenbos H
    Neth J Med; 1974; 17(4-5):234-8. PubMed ID: 4465730
    [No Abstract]   [Full Text] [Related]  

  • 17. Insulin antibodies in diabetes.
    Lev-Ran A; Joshua H; Mannheimer S
    Isr J Med Sci; 1971 Sep; 7(9):1035-9. PubMed ID: 5170197
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical aspects of monocomponent insulins in the treatment of diabetes.
    Vinik AI; Joffe BI; Seftel HC; Distiller LA; Jackson WP
    S Afr Med J; 1976 Apr; 50(15):587-91. PubMed ID: 1265555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-peptide antibodies induced by bovine insulin therapy.
    Reeves WG; Douglas CA
    Clin Exp Immunol; 1982 Oct; 50(1):171-7. PubMed ID: 6756729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin binding and free insulin in serum of insulin-treated diabetics.
    Lev-Ran A; Ratt L
    Horm Metab Res; 1973 Mar; 5(2):67-70. PubMed ID: 4707702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.